7. Inhaled Combination Therapy with Glucocorticoids and Long-Acting β2-Agonists in Asthma and COPD, Current and Future Perspectives

  1. Jan Lötvall
  1. Jan Lötvall

Published Online: 29 FEB 2012

DOI: 10.1002/9781119998624.ch7

Advances in Combination Therapy for Asthma and COPD

Advances in Combination Therapy for Asthma and COPD

How to Cite

Lötvall, J. (2012) Inhaled Combination Therapy with Glucocorticoids and Long-Acting β2-Agonists in Asthma and COPD, Current and Future Perspectives, in Advances in Combination Therapy for Asthma and COPD (ed J. Lötvall), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998624.ch7

Editor Information

  1. Krefting Research Centre, University of Gothenburg, Göteborg, Sweden

Author Information

  1. Krefting Research Centre, University of Gothenburg, Göteborg, Sweden

Publication History

  1. Published Online: 29 FEB 2012
  2. Published Print: 3 FEB 2012

ISBN Information

Print ISBN: 9780470727027

Online ISBN: 9781119998624

SEARCH

Keywords:

  • inhaled combination therapy with glucocorticoids;
  • pharmacological guidelines;
  • asthma, and steroid treatment;
  • steroid treatment, in COPD;
  • combination inhalers;
  • inhaled GCS and LABAs;
  • combination inhalers, availability;
  • alternative combinations, inhaled GCS and LABAs

Summary

This chapter contains sections titled:

  • Pharmacological management guidelines of asthma and COPD

  • Steroid treatment in asthma

  • Effects of adding LABA to inhaled glucocorticoids in asthma

  • Steroid treatment in COPD

  • Effects of LABAs in COPD

  • Combination inhalers versus two separate inhalers for inhaled GCS and LABAs

  • Regular treatment alone versus additional formoterol-containing combinations as reliever therapy

  • Currently available combination inhalers

  • Upcoming and alternative combinations of inhaled GCS and LABAs

  • Future of combined inhalation therapy in respiratory disease

  • References